The Oncology Insights Podcast - Dr. Timothy Burns: Precision Lung Cancer Therapy | Ep. 15

In this episode of The Oncology Insights Podcast, Dr. Timothy Burns from The Ohio State University explains why progress depends on more than identifying a mutation. The field must also understand resistance, improve drug selectivity, reach metastatic disease in the brain, and determine when combination therapy adds meaningful benefit.

What you’ll learn:

• KRAS inhibitor evolution
• Targeted therapy resistance
• Biomarker testing strategy
• Systemic therapy combinations
• Future strategies and AI applications

Meet the guest:

Dr. Timothy Burns is Professor of Medicine at The Ohio State University Comprehensive Cancer Center. With more than 89 publications and NCI R01 funding, his research advances targeted therapies for oncogene-driven NSCLC and brain metastases. He has led multiple clinical trials, including early-phase studies contributing to the approval of the KRAS G12C inhibitor sotorasib. Listen to Dr. Timothy Burns on The Oncology Insights Podcast, available on all major platforms.

Liked this one? Don’t stop now. Here's what we think you'll love!